DRKS00010889招募中不适用
Detection and analysis of HCV resistance to new HCV drugs and autologous antibody responses - PEPSI-II
niversität zu Köln0 个研究点目标入组 10,000 人开始时间: 2017年2月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 10,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •confirmed replicative HCV-infection; intended start of renewed DAA-therapy; mental capacity; signed informed consent
排除标准
- •age < 18 years
研究者
相似试验
已完成
不适用
Changes of resistance-associated variants in HCV NS5A region post vitamin D supplementation for patients with chronic hepatitis CChronic hepatitis CJPRN-UMIN000018454ippon Medical School Chiba Hokusoh Hospital30
已完成
不适用
Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With TelaprevirChronic Hepatitis CNCT01577069Association HGE CHU Bordeaux Sud73
进行中（未招募）
1 期
Protecting immune responses in patients treated with the new DAA anti hepatitis C alone or in combination with previously used medications (interferon and ribavirin)EUCTR2015-003024-31-ITAZIENDA OSPEDALIERO-UNIVERSITARIA DI PARMA30
进行中（未招募）
1 期
treatment of eradication of HCV infection in immigrant patients with innovative drugChronic HCV hepatitis, all fibrosisMedDRA version: 20.1Level: PTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: PTClassification code 10019755Term: Hepatitis chronic activeSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2017-001024-21-ITA.O.U. Università degli Studi della Campania Luigi Vanvitelli6,000
进行中（未招募）
1 期
Hepatitis C virusdynamik og immunaktivering hos HCV/HIV-koinficerede patienter under behandling med pegyleret interferon a-2a og ribavirin - DICO-DHIV-infection and concomittant HCV-infectionEUCTR2005-002202-28-DKRigshospitalet20